FINWIRES · TerminalLIVE
FINWIRES

Top Midday Stories: Strong Nvidia, Salesforce, CrowdStrike Earnings Help Drive Stock Indexes Higher

By

All three major US stock indexes were up in late-morning trading Thursday, after Nvidia (NVDA) released their highly anticipated earnings results on Wednesday after markets closed.

In company news, Nvidia reported fiscal Q2 adjusted earnings late Wednesday of $2.22 per diluted share, up from $1.01 a year earlier and above the FactSet consensus analyst estimate of $2.09. Fiscal Q2 revenue was $96.22 billion, up from $46.74 billion a year ago and above the FactSet consensus of $92.27 billion. For fiscal Q3, the company expects revenue of $108 billion, plus or minus 2%. Analysts polled by FactSet expect $104.86 billion. Separately, Nvidia has agreed to buy Hugging Fact, the open-source AI platform, for $12.9 billion, The Information reported late Wednesday. Lastly, Nvidia and Amazon's (AMZN) AWS plan to deploy 2 million additional Nvidia GPUs across AWSs global infrastructure in 2027-2028, the companies said. Nvidia shares were up 7.6% around midday.

Salesforce (CRM) reported fiscal Q2 adjusted EPS late Wednesday of $5.90, up from $2.91 a year earlier and above the FactSet consensus of $3.27. Fiscal Q2 revenue was $11.35 billion, up from $10.24 billion a year ago and above the FactSet consensus of $11.33 billion. For fiscal Q3, the company expects adjusted EPS of $3.42 to $3.44 on revenue of $11.42 billion to $11.50 billion. Analysts polled by FactSet expect $3.37 and $11.42 billion, respectively. For fiscal 2027, Salesforce expects adjusted EPS of $16.67 to $16.71 on revenue of $46.1 billion to $46.4 billion, up from their prior forecast of adjusted EPS of $14.06 to $14.12 on revenue of $45.9 billion to $46.2 billion. Analysts expect $14.16 and $46.11 billion, respectively. Separately, Salesforce and Anthropic said they were expanding their partnership to pair Claude's intelligence and reasoning with Salesforce's enterprise platform under the name Claudeforce. Salesforce shares were up about 19%.

CrowdStrike (CRWD) reported fiscal Q2 adjusted EPS late Wednesday of $0.31, up from $0.23 a year earlier and above the FactSet consensus of $0.29. Fiscal Q2 revenue was $1.47 billion, up from $1.17 billion a year ago and above the FactSet consensus of $1.44 billion. For fiscal Q3, the company said it expects adjusted EPS of $0.31 on revenue of $1.523 billion to $1.529 billion. Analysts expect $0.31 and $1.51 billion, respectively. For fiscal 2027, CrowdStrike expects adjusted EPS of $1.25 to $1.26 on revenue of $5.99 billion to $6.01 billion. Analysts expect EPS of $1.23 on revenue of $5.94 billion. CrowdStrike shares were up 17.7%.

Moderna (MRNA) plans to offer $2 billion worth of convertible senior notes due 2032 in a private placement, the company said Thursday. The company plans to grant initial purchasers a 13-day option to acquire up to $300 million worth of additional shares, Moderna said. Shares of Moderna were down 7.1%.

Best Buy (BBY) reported fiscal Q2 adjusted EPS Thursday of $1.47, up from $1.28 a year earlier and above the FactSet consensus of $1.39. Fiscal Q2 revenue was $9.78 billion, up from $9.44 billion a year ago and above the FactSet consensus of $9.59 billion. For fiscal 2027, the company expects adjusted EPS of $6.70 to $6.90, up from its prior outlook of $6.30 to $6.60. The retailer also expects full-year revenue of $42.30 billion to $42.80 billion, up from its prior guidance of $41.20 billion to $42.10 billion. Analysts expect EPS of $6.62 on revenue of $42.08 billion. The company also said it expects fiscal 2027 comparable sales growth of 1.9% to 3%, up from its prior guidance of a decline of 1% to growth of 1%. Best Buy shares were down 4.4%.

Price: $225.41, Change: $+15.75, Percent Change: +7.51%

Related Articles

Wire

Update: Magellan Financial Group Fiscal 2026 Operating Earnings, Revenue Down; Shares Fall 12%

(Updates to add stock movement in the headline and the last paragraph)Magellan Financial Group (ASX:MFG) logged AU$0.828 in operating earnings per share for fiscal 2026, compared with AU$0.898 a year ago, a Thursday filing showed.For the 12 months ended June 30, revenue and other income was AU$195.6 million versus AU$318.9 million previously, the Australia-listed financial services firm added.The board declared a final dividend of AU$0.255 per share, payable Sept. 16 to shareholders on record as of Sept. 2. A year ago, the company paid a final dividend AU$0.259 per share and special dividend of AU$0.21 per share.The board has revised the group's dividend policy from fiscal 2027, targeting a payout ratio of 60% to 90% of operating profit after tax.The company's shares fell 12% in recent Thursday trade.

ASX:MFG
Wire

Tenable to Join S&P SmallCap 600 Index

Tenable (TENB) will join the S&P SmallCap 600 index before market open on Aug. 31, the S&P Dow Jones Indices said in a late Wednesday statement.Tenable will replace Leggett & Platt (LEG), which is being acquired by Somnigroup International (SGI), according to the statement.

$LEG$SGI$TENB
Wire

NeoGenomics Wins Expanded Medicare Coverage for RaDaR ST Immunotherapy Monitoring

NeoGenomics (NEO) said its RaDaR ST molecular residual disease assay received expanded Medicare coverage to include immunotherapy response monitoring for patients with late-stage solid tumors.The determination from the Centers for Medicare & Medicaid Services' Molecular Diagnostic Services Program is the third Medicare-covered indication for RaDaR ST, NeoGenomics said Wednesday in a statement.The coverage allows use of the assay to monitor response to immune-checkpoint inhibitor therapy, and NeoGenomics said it has two additional RaDaR ST submissions pending.NeoGenomics shares rose 2.1% in after-hours trading.

$NEO